Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study on Pharmacokinetics of Bomedemstat (MK-3543) Final Market Formulation in Healthy Participants
jRCT2071250127Phase 1Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bomedemstat in thrombocythemia, sponsored by Merck & Co. Primary endpoint: MK-3543 pharmacokinetics. Started Feb 2026; status: completed.
02
Drugs
bomedemstat
03
Conditions
thrombocythemia
Beyond the preview
Go deeper on jRCT2071250127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250127.